Wednesday, October 21, 2020

admin

809 POSTS2 COMMENTS

UK inks deal with Abingdon Health for rapid COVID-19 antibody tests

October 7, 2020: "The UK authorities has introduced a deal with Abingdon Health for the provision of the corporate’s AbC-19 rapid COVID-19...

BMS Opdivo plus Yervoy misses the mark in high-risk melanoma Patients

October 02, 2020: "Bristol Myers Squibb announced results for the co-primary endpoint for CheckMate -915, a randomized Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) versus Opdivo for...

COVID-19 disrupting mental health services in most countries, WHO survey

October 05, 2020: The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand...

Novartis Beovu® showed improvement in best-corrected visual acuity in wet AMD patients with early persistent fluid

October 5, 2020: "Novartis announced that results of two new post-hoc analyses of the Phase III HAWK and HARRIER clinical trials in wet...

COVID-19 vaccine AZD1222 clinical trial resumed in Japan

 October 2020: "The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals...

Two days Crash-Course on Pharmacovigilance

Specially designed Course for Freshers and entry Level Professionals on Pharmacovigilance is going to be held On 10 Oct (Saturday): 04:00-06:00pm and...

FDA Ok Eton Pharmaceuticals ALKINDI® SPRINKLE as Replacement Therapy in Pediatric Patients

 Sept. 29, 2020: "Eton Pharmaceuticals, a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced...

New contract with UK DHSC for instrument platforms and COVID-19 testing kits

29 September 2020: "Novacy, an international specialist in clinical diagnostics, announces it has signed a new supply contract with the UK Department...

FDA Issues Final Guidance for Certain Labeling Recommendations for Breast Implants

September 28, 2020: "The U.S. FDA issued the final guidance, “Breast Implants - Certain Labeling Recommendations to Improve Patient Communication,” as part...

Global partnership to make available 120 million affordable, quality COVID-19 rapid tests

September 28, 2020 : A set of agreements to make available, for low and middle-income countries, affordable, high-quality COVID-19 antigen rapid tests were...

ViiV Healthcare announces start of the CARISEL study for injectable treatment for HIV

September 28, 2020: "ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders...

UK and EU pharma call for medicines to be prioritised in Brexit trade talks

September 28, 2020: "The ABPI and EFPIA have both emphasised the need for trade talks to mitigate medicine supply chain disruptions following...

TOP AUTHORS

809 POSTS2 COMMENTS

Most Read

AZ’s Tagrisso scores priority review from FDA with EGFR-mutated lung cancer

October 20, 2020: "AstraZeneca’s Tagrisso (osimertinib) has received acceptance for its supplemental New Drug Application (sNDA) and has also been granted Priority Review in...

Forxiga recommended for approval in the EU by CHMP for heart failure

October 19, 2020: "AstraZeneca’s Forxiga (dapagliflozin) has been recommended for an indication extension of its marketing authorisation in the European Union (EU) for the...

AstraZeneca advances leadership in renal disease at ASN Kidney Week 2020 Reimagined

October 20, 2020: AstraZeneca will present 84 abstracts, including 12 oral presentations and three late-breaking abstracts, across its industry-leading renal portfolio which...

AbbVie’s VENCLEXTA® Receives FDA Approval for Acute Myeloid Leukemia

October 16, 2020: "AbbVie announced that the U.S. Food and Drug Administration (FDA) has provided full approval to VENCLEXTA® (venetoclax) in combination...